+Search query
-Structure paper
Title | Preclinical proof of principle for orally delivered Th17 antagonist miniproteins. |
---|---|
Journal, issue, pages | Cell, Vol. 187, Page 4305-, Year 2024 |
Publish date | Oct 31, 2023 (structure data deposition date) |
Authors | Berger, S. / Seeger, F. / Yu, T.Y. / Aydin, M. / Yang, H. / Rosenblum, D. / Guenin-Mace, L. / Glassman, C. / Arguinchona, L. / Sniezek, C. ...Berger, S. / Seeger, F. / Yu, T.Y. / Aydin, M. / Yang, H. / Rosenblum, D. / Guenin-Mace, L. / Glassman, C. / Arguinchona, L. / Sniezek, C. / Blackstone, A. / Carter, L. / Ravichandran, R. / Ahlrichs, M. / Murphy, M. / Pultz, I.S. / Kang, A. / Bera, A.K. / Stewart, L. / Garcia, K.C. / Naik, S. / Spangler, J.B. / Beigel, F. / Siebeck, M. / Gropp, R. / Baker, D. |
External links | Cell / PubMed:38936360 |
Methods | X-ray diffraction |
Resolution | 1.94 Å |
Structure data | PDB-8utk: |
Chemicals | ChemComp-PG6: ChemComp-SO4: ChemComp-PG5: ChemComp-HOH: |
Source |
|
Keywords | DE NOVO PROTEIN / Computational design / selective inhibitors / IL-2 IL-17 cytokines DE NOVO PROTEIN |